Acne vulgaris, inflammatory, moderate to severe (Gianvi, Jasmiel, Lo-Zumandimine, Loryna, Nikki, Vestura, Yaz only): Treatment of moderate acne vulgaris in patients ≥14 years of age only if the patient desires an oral contraceptive for birth control.
Limitations of use: For use only in patients who have reached menarche, are unresponsive to topical acne treatments, and have no contraindications to combination hormonal contraceptive use.
Contraception: For the prevention of pregnancy.
Limitations of use: For use in patients who may become pregnant; not for use prior to menarche or post menopause.
Premenstrual dysphoric disorder (Gianvi, Jasmiel, Lo-Zumandimine, Loryna, Nikki, Vestura, Yaz only): Treatment of premenstrual dysphoric disorder for patients who choose to use an oral contraceptive for contraception.
Limitations of use: Use for more than 3 menstrual cycles has not been evaluated. Has not been evaluated for the treatment of premenstrual syndrome.